Alprazolam
Sold as Xanor, Biozane, Anxirid, Azor, Xanor sr, Adco-alzam, Adco alzam, Zopax, Apotex-alprazolam, Alprazolam biotech, Xanolam, Coprax, Propan alprazolam, Alprazolam unicorn, Mylan alprazolam, Adco-alprazolam, Novapraz xr
8-Chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
Drag to rotate. Structure from PubChem CID 2118.
Background
Registration
- Applicants
- 10
- Registrations
- 39
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Viatris Healthcare (Pty) Ltd | Xanor, Xanor sr, Mylan alprazolam | 0,25 mg, 0,5 mg, 1,0 mg, 2,0 mg | 270096, 290504, 290505, 290506, 320323, 320372, 320373, M0233, M0234 | S5 | None |
| Biotech Laboratories (Pty) Ltd | Biozane, Alprazolam biotech | 0,5 mg, 1 mg, 10 mg/200 mg/350 mg | 280001, 280002, 310012, 310014 | S5 | PIPIL |
| Pharmacare limited û woodmead2 of 5 cancelled | Anxirid, Azor | 0,25, 0,5 mg, 1,0 mg | 280088, 280113, 290180, 290181, 290182 | S5 | None |
| Adcock ingram limited3 of 9 cancelled | Adco-alzam, Adco alzam, Propan alprazolam, Alprazolam unicorn, Adco-alprazolam | 0,25 mg, 0,5 mg, 1,0 mg, 1 mg | 300211, 300212, 300213, 320153, 320154, 320155, 330486, 330487, 330488 | S5 | None |
| Cipla Medpro (Pty) LtdCancelled | Zopax | 0,25, 0,5, 1,0 | 300264, 300357, 300358 | S5 | None |
| Apotex SA (Pty) LtdCancelled | Apotex-alprazolam | 0,25 mg | 310013 | S5 | None |
| Garec (Pty) LtdCancelled | Xanolam | 0,5 mg | 310015 | S5 | None |
| Pharma-q Holdings (Pty) Ltd | Coprax | 0,25, 0,5, 1,0 | 310240, 310241, 310242 | S5 | None |
| Novagen Pharma (Pty) LtdCertificate held by Novagen Pharma (Pty) Ltd.1 of 3 cancelled | Novapraz xr | 0,5, 1, 2 | 510435, 510436, 510437 | S5 | PIPIL |
| Upjohn South Africa (Pty) Ltd | Xanor | 1 mg | M0235 | S5 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Xanor 2,0 MG EACH TABLET CONTAINS ALPRAZOLAM 2,0 mg | 2,0 mg | 27009627/2.6/0096 | Registered | S5 | None |
| Biozane 0,5 MG EACH TABLET CONTAINS ALPRAZOLAM 0,5 mg | 0,5 mg | 28000128/2.6/0001 | Registered | S5 | None |
| Biozane 1 MG EACH TABLET CONTAINS ALPRAZOLAM 1 mg | 1 mg | 28000228/2.6/0002 | Registered | S5 | None |
| Anxirid 1,0 MG tablets EACH TABLET CONTAINS ALPRAZOLAM 1 mg | 1,0 mgTablets | 28008828/2.6/0088 | Cancelled | S5 | None |
| Anxirid 0,5 MG tablets EACH TABLET CONTAINS ALPRAZOLAM 0,5 mg | 0,5 mgTablets | 28011328/2.6/0113 | Cancelled | S5 | None |
| Azor - 0,25 EACH TABLET CONTAINS ALPRAZOLAM 0,25 mg | - 0,25 | 29018029/2.6/0180 | Registered | S5 | None |
| Azor-0,5 EACH TABLET CONTAINS ALPRAZOLAM 0,5 MG | 0,5 | 29018129/2.6/0181 | Registered | S5 | None |
| Azor-1,0 EACH TABLET CONTAINS ALPRAZOLAM 1,0 MG | 1,0 | 29018229/2.6/0182 | Registered | S5 | None |
| Xanor sr 0,5 MG EACH TABLET CONTAINS ALPRAZOLAM 0,50 mg | 0,5 mg | 29050429/2.6/0504 | Registered | S5 | None |
| Xanor sr 1,0 MG EACH TABLET CONTAINS ALPRAZOLAM 1 mg | 1,0 mg | 29050529/2.6/0505 | Registered | S5 | None |
| Xanor sr 2,0 MG EACH TABLET CONTAINS ALPRAZOLAM 2 mg | 2,0 mg | 29050629/2.6/0506 | Registered | S5 | None |
| Adco-alzam 0,5 MG EACH TABLET CONTAINS :ALPRAZOLAM 0,5 mg | 0,5 mg | 30021130/2.6/0211 | Registered | S5 | None |
| Adco-alzam 0,25 MG TABLET ALPRAZOLAM 0,25 MG | 0,25 mg | 30021230/2.6/0212 | Registered | S5 | None |
| Adco alzam 1,0 MG EACH TABLET CONTAINS ALPRAZOLAM 1,0 mg | 1,0 mg | 30021330/2.6/0213 | Registered | S5 | None |
| Zopax 0,25 EACH TABLET CONTAINS: ALPRAZOLAM 0,25 mg | 0,25 | 30026430/2.6/0264 | Cancelled | S5 | None |
| Zopax 0,5 EACH TABLET CONTAINS ALPRAZOLAM 0,5 mg | 0,5 | 30035730/2.6/0357 | Cancelled | S5 | None |
| Zopax 1,0 EACH TABLET CONTAINS ALPRAZOLAM 1,0 mg | 1,0 | 30035830/2.6/0358 | Cancelled | S5 | None |
| Biozane 0,25 EACH TABLET CONTAINS ALPRAZOLAM 0,25 mg | 10 mg/200 mg/350 mgTablets | 31001231/2.6/0012Approved 19 August 2025 | Registered | S5 | PIPIL |
| Apotex-alprazolam 0,25 MG EACH TABLET CONTAINS ALPRAZOLAM 0,25 mg | 0,25 mg | 31001331/2.6/0013 | Cancelled | S5 | None |
| Alprazolam biotech 0,5 EACH TABLET CONTAINS ALPRAZOLAM 0,5 mg | 0,5 | 31001431/2.6/0014 | Registered | S5 | None |
| Xanolam 0,5 MG EACH TABLET CONTAINS ALPRAZOLAM 0,5 mg | 0,5 mg | 31001531/2.6/0015 | Cancelled | S5 | None |
| Coprax 0,25 EACH TABLET CONTAINS ALPRAZOLAM 0,25 mg | 0,25 | 31024031/2.6/0240 | Registered | S5 | None |
| Coprax 0,5 EACH TABLET CONTAINS ALPRAZOLAM 0,5 mg | 0,5 | 31024131/2.6/0241 | Registered | S5 | None |
| Coprax 1,0 EACH TABLET CONTAINS ALPRAZOLAM 1,0 mg | 1,0 | 31024231/2.6/0242 | Registered | S5 | None |
| Propan alprazolam 0,25 MG EACH TABLET CONTAINS ALPRAZOLAM 0,25 mg | 0,25 mg | 32015332/2.6/0153 | Registered | S5 | None |
| Alprazolam unicorn 0,5 MG EACH TABLET CONTAINS ALPRAZOLAM 0,5 mg | 0,5 mg | 32015432/2.6/0154 | Registered | S5 | None |
| Alprazolam unicorn 1,0 MG EACH TABLET CONTAINS ALPRAZOLAM 1,0 mg | 1,0 mg | 32015532/2.6/0155 | Registered | S5 | None |
| Mylan alprazolam 1,0 MG EACH TABLET CONTAINS ALPRAZOLAM 1,0 mg | 1,0 mg | 32032332/2.6/0323 | Registered | S5 | None |
| Mylan alprazolam 0,25 MG EACH TABLET CONTAINS ALPRAZOLAM 0,25 mg | 0,25 mg | 32037232/2.6/0372 | Registered | S5 | None |
| Mylan alprazolam 0,5 MG EACH TABLET CONTAINS ALPRAZOLAM 0,5 mg | 0,5 mg | 32037332/2.6/0373 | Registered | S5 | None |
| Adco-alprazolam 0,25 MG EACH TABLET CONTAINS ALPRAZOLAM 0,25 mg | 0,25 mg | 33048633/2.6/0486 | Cancelled | S5 | None |
| Adco-alprazolam 0,5 MG EACH TABLET CONTAINS ALPRAZOLAM 0,50 mg | 0,5 mg | 33048733/2.6/0487 | Cancelled | S5 | None |
| Adco-alprazolam 1 MG EACH TABLET CONTAINS ALPRAZOLAM 1,0 mg | 1 mg | 33048833/2.6/0488 | Cancelled | S5 | None |
| Novapraz xr 0,5 | 0,5Extended release tablets (xr) | 51043551/2.6/0435Approved 5 March 2021 | Registered | S5 | PIPIL |
| Novapraz xr 1 | 1Extended release tablets (xr) | 51043651/2.6/0436Approved 5 March 2021 | Registered | S5 | PIPIL |
| Novapraz xr 2 EACH TABLET CONTAINS: ALPRAZOLAM 2,0 mg | 2Extended release tablets (xr) | 51043751/2.6/0437Approved 5 March 2021 | Cancelled | S5 | PIPIL |
| Xanor 0,25 MG EACH TABLET CONTAINS ALPRAZOLAM 0,25 mg | 0,25 mg | M0233M/2.6/233 | Registered | S5 | None |
| Xanor 0,5 MG EACH TABLET CONTAINS ALPRAZOLAM 0,5 mg | 0,5 mg | M0234M/2.6/234 | Registered | S5 | None |
| Xanor 1 MG EACH TABLET CONTAINS ALPRAZOLAM 1,0 mg | 1 mg | M0235M/2.6/235 | Registered | S5 | None |
Regulatory status
Where S5 sits on the scale
Prescription-only, with tighter controls on repeats.
Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S5, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.
Consolidated Schedules listings for Alprazolam
S5: Alprazolam
Consolidated Schedules 06 July 2026, line 9202
Pharmacological class: Tranquillisers. (class 2.6)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Biozane 0,25, Biotech Laboratories (Pty) Ltd is scheduled S5 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.